Drug Price Trends for OMEPRAZOLE-BICARB

Average Pharmacy Cost for OMEPRAZOLE-BICARB

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
OMEPRAZOLE-BICARB 20-1,100 CAP	69097-0913-02	0.70842	EACH	2025-03-19
OMEPRAZOLE-BICARB 20-1,100 CAP	27241-0031-03	0.70842	EACH	2025-03-19
OMEPRAZOLE-BICARB 40-1,680 PKT	68682-0991-30	12.75775	EACH	2025-03-19

Omeprazole and Sodium Bicarbonate Market Analysis and Price Projections

Market Overview

The market for omeprazole and sodium bicarbonate, commonly used in the treatment of gastrointestinal disorders, is experiencing significant growth driven by several key factors.

Market Size and Growth

The omeprazole and antihistamine market, which includes omeprazole and sodium bicarbonate formulations, is projected to register a Compound Annual Growth Rate (CAGR) of 5.70% during the forecast period from 2024 to 2029[1].

On a broader scale, the omeprazole market alone is valued at USD 1.13 billion in 2024 and is expected to exceed USD 2.56 billion by 2037, growing at a CAGR of over 6.5% during the forecast period of 2025-2037[3].

Key Drivers of Market Growth

Increasing Prevalence of Gastrointestinal Disorders

The growing prevalence of gastroesophageal reflux disease (GERD), gastric ulcers, and other gastrointestinal conditions is a major driver of market growth. For instance, GERD affects 20% of adults in Western societies, and regurgitation or vomiting in infants, which can be indicative of GERD, is reported in up to 41% of healthy infants between three and four months of age[1].

Demand for Over-the-Counter (OTC) Medications

The increasing demand for over-the-counter medications is another significant factor. Omeprazole and sodium bicarbonate formulations are widely available as OTC drugs, making them more accessible to consumers[1].

Product Approvals and Launches

Recent product approvals, such as the FDA approval for Azurity Pharmaceuticals' Konvomep (omeprazole and sodium bicarbonate for oral suspension) in September 2022, are also driving market growth. These approvals expand the treatment options available for patients with gastrointestinal disorders[1].

Market Segmentation

Product Type

The market is segmented by product type, with omeprazole and sodium bicarbonate being key components. The capsule segment is expected to dominate the market, projected to occupy 52% of the market share by 2037[3].

Indications

The market is divided by indications such as gastric ulcer, gastroesophageal reflux disease, duodenal ulcer, erosive esophagitis, and others. The prevalence of these conditions, particularly GERD and peptic ulcers, is high in regions like North America, contributing to the market's growth[1][3].

Distribution Channels

The market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The ease of access through these channels, especially online pharmacies, has increased the market's reach and convenience for consumers[1].

Regional Analysis

North America

North America holds the largest market share due to the high prevalence of gastrointestinal disorders such as gastric ulcers and GERD. The region is expected to continue dominating the market, driven by factors like product launches and the increasing burden of gastrointestinal diseases[1].

Asia Pacific

The Asia Pacific region is the fastest-growing market, driven by increasing healthcare awareness and the rising incidence of chronic diseases. This region is anticipated to grow at the highest CAGR over the forecast period[1].

Market Leaders

The omeprazole and sodium bicarbonate market is consolidated, with major players including Bayer AG, Novartis, Pfizer, Procter & Gamble, and Teva Pharmaceutical. These companies are known for their global and regional presence and hold significant market shares[1].

Pricing and Cost Analysis

Omeprazole/Sodium Bicarbonate Prices

The cost for omeprazole/sodium bicarbonate formulations varies based on the dosage form and quantity. For example:

• A supply of 42 capsules of omeprazole/sodium bicarbonate (20 mg-1100 mg) can cost around $20.38 for cash-paying customers[2].
• The brand name version, Zegerid, can cost significantly more, with a supply of 30 capsules (20 mg-1100 mg) priced around $3,491.58[5].

Generic and Brand Name Versions

Generic versions of omeprazole/sodium bicarbonate are available at lower prices compared to brand name versions like Zegerid. This makes the generic options more affordable for consumers[2][5].

Challenges and Opportunities

Challenges

Despite the growth, the market faces challenges such as stock shortages and pricing variability, which can affect consumer expectations and market stability[2][5].

Opportunities

The increasing demand for effective therapeutics, especially in regions with high prevalence of gastrointestinal disorders, presents significant opportunities for market growth. Positive results from clinical trials, such as those involving omeprazole in H. pylori elimination therapy, further bolster the market's potential[1][3].

Key Takeaways

• The omeprazole and sodium bicarbonate market is expected to grow at a CAGR of 5.70% from 2024 to 2029.
• North America holds the largest market share, while the Asia Pacific region is the fastest-growing.
• Increasing prevalence of GERD and other gastrointestinal disorders, along with product approvals and launches, drive market growth.
• The market is segmented by product type, indications, and distribution channels.
• Major players include Bayer AG, Novartis, Pfizer, Procter & Gamble, and Teva Pharmaceutical.
• Generic versions of omeprazole/sodium bicarbonate are more affordable than brand name versions.

FAQs

What is the current market size of the omeprazole and antihistamine market?

The omeprazole and antihistamine market is projected to register a CAGR of 5.70% during the forecast period (2024-2029), but the exact current market size is not specified in the sources provided.

Who are the key players in the omeprazole and sodium bicarbonate market?

Key players include Bayer AG, Novartis, Pfizer, Procter & Gamble, and Teva Pharmaceutical.

Which region has the largest share in the omeprazole and sodium bicarbonate market?

North America accounts for the largest market share in the omeprazole and sodium bicarbonate market.

What are the primary indications for omeprazole and sodium bicarbonate?

Primary indications include gastric ulcer, gastroesophageal reflux disease, duodenal ulcer, and erosive esophagitis.

How much does a supply of omeprazole/sodium bicarbonate typically cost?

A supply of 42 capsules of omeprazole/sodium bicarbonate (20 mg-1100 mg) can cost around $20.38 for cash-paying customers, while brand name versions like Zegerid can be significantly more expensive.

Sources

1. Mordor Intelligence: Omeprazole And Antihistamine Market Size & Share Analysis
2. Drugs.com: Omeprazole/sodium bicarbonate Prices, Coupons, Copay Cards & Patient Assistance
3. Research Nester: Omeprazole Market Size & Share | Growth Forecasts 2037
4. Market Research Reports: Global Omeprazole Sodium Bicarbonate Capsules Market Research Report 2024
5. Drugs.com: Zegerid Prices, Coupons, Copay Cards & Patient Assistance